. Annexe, Questionnaire sur les critères Rome IV du syndrome de l'intestin irritable, p.157

B. Bibliographie-1, S. Leucht, A. Cipriani, L. Spineli, D. Mavridis et al., Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments metaanalysis, Lancet Lond Engl. 14 sept, vol.382, issue.9896, pp.951-62, 2013.

A. Association, M. Crocq, J. Guelfi, P. Boyer, C. Pull et al., DSM-5 -Manuel diagnostique et statistique des troubles mentaux. 5e édition, 2015.

D. Goldberg, Diagnostic Issues in Depression and Generalized Anxiety Disorder: Refining the Research Agenda for Dsm-v. 1 edition, 2010.

J. Guelfi and F. Rouillon, Manuel de psychiatrie. 3e édition. Issy-les-Moulineaux, 2017.

A. Amad, V. Camus, P. Geoffroy, P. Thomas, and O. Cottencin, Référentiel de psychiatrie et addictologie : Psychiatrie de l'adulte, psychiatrie de l'enfant et de l'adolescent, addictologie. 2e édition. Tours: Presses universitaire François Rabelais, 2016.

M. Rosenhan, D. L. Walker, M. Rosenhan, E. F. Seligman, and . Walker, Abnormal Psychology (text only) 4th (Fourth) edition by D, 2000.

S. Stahl, N. Muntner, and P. Lemoine, Psychopharmacologie essentielle : Bases neuroscientifiques et applications pratiques. 4e édition, 2015.

T. Frodl, E. Reinhold, N. Koutsouleris, G. Donohoe, B. Bondy et al., Childhood Stress, Serotonin Transporter Gene and Brain Structures in Major Depression, Neuropsychopharmacology, vol.12, issue.6, pp.1383-90, 2010.
DOI : 10.1016/0006-8993(90)90778-A

URL : https://hal.archives-ouvertes.fr/hal-00509101

L. Booij, M. Szyf, A. Carballedo, E. Frey, D. Morris et al., DNA Methylation of the Serotonin Transporter Gene in Peripheral Cells and Stress-Related Changes in Hippocampal Volume: A Study in Depressed Patients and Healthy Controls, PLOS ONE, vol.35, issue.2, p.119061, 2015.
DOI : 10.1371/journal.pone.0119061.s001

. Institut-national-de-la-santé-et-de-la-recherche, Stress au travail et santé : Situation chez les indépendants [Internet]. Les éditions Inserm, 2011.

R. Krishnadas and J. Cavanagh, Depression: an inflammatory illness?: Figure 1, Journal of Neurology, Neurosurgery & Psychiatry, vol.83, issue.5, pp.495-502, 2012.
DOI : 10.1136/jnnp-2011-301779

URL : http://jnnp.bmj.com/content/jnnp/83/5/495.full.pdf

A. Patel, Review: the role of inflammation in depression, Psychiatr Danub. sept, vol.25, issue.2, pp.216-223, 2013.

A. Lopresti, G. Maker, S. Hood, and P. Drummond, A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.48, pp.102-113, 2014.
DOI : 10.1016/j.pnpbp.2013.09.017

A. Miller and C. Raison, The role of inflammation in depression: from evolutionary imperative to modern treatment target, Nature Reviews Immunology, vol.31, issue.1, pp.22-34, 2016.
DOI : 10.1016/j.bbi.2013.04.004

M. Howren, D. Lamkin, and J. Suls, Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis, Psychosomatic Medicine, vol.71, issue.2, pp.171-86, 2009.
DOI : 10.1097/PSY.0b013e3181907c1b

O. Köhler-forsberg, H. Buttenschøn, K. Tansey, W. Maier, J. Hauser et al., Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression, Brain, Behavior, and Immunity, vol.62
DOI : 10.1016/j.bbi.2017.02.020

D. Riché and D. Chos, Ne nourrissez plus votre douleur micronutrition et fibromyalgie, 2013.

J. Hannestad, N. Dellagioia, and M. Bloch, The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol, nov, vol.36, issue.12, pp.2452-2461, 2011.

M. Maes, I. Mihaylova, M. Ruyter, M. Kubera, and E. Bosmans, The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression -and other conditions characterized by tryptophan depletion induced by inflammation, Neuro Endocrinol Lett. déc, vol.28, issue.6, pp.826-857, 2007.

M. Maes, B. Leonard, A. Myint, M. Kubera, and R. Verkerk, The new ???5-HT??? hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.35, issue.3, pp.702-723, 2011.
DOI : 10.1016/j.pnpbp.2010.12.017

A. Slyepchenko, M. Maes, R. Machado-vieira, G. Anderson, M. Solmi et al., Intestinal Dysbiosis, Gut Hyperpermeability and Bacterial Translocation: Missing Links Between Depression, Obesity and Type 2 Diabetes, Current Pharmaceutical Design, vol.22, issue.40, pp.6087-106, 2016.
DOI : 10.2174/1381612822666160922165706

Z. Wang, J. Gu, X. Wang, K. Xie, Q. Luan et al., Antidepressant-like activity of resveratrol treatment in the forced swim test and tail suspension test in mice: The HPA axis, BDNF expression and phosphorylation of ERK, Pharmacology Biochemistry and Behavior, vol.112, pp.104-114, 2013.
DOI : 10.1016/j.pbb.2013.10.007

K. Terada, N. Izumo, B. Suzuki, Y. Karube, T. Morikawa et al., Fluvoxamine moderates reduced voluntary activity following chronic dexamethasone infusion in mice via recovery of BDNF signal cascades, Neurochemistry International, vol.69, pp.9-13, 2014.
DOI : 10.1016/j.neuint.2014.02.002

S. Stahl, N. Muntner, and P. Lemoine, Psychopharmacologie essentielle : Le guide du prescripteur, 2016.
DOI : 10.1016/s1627-4830(07)89980-6

R. Spiller, Q. Aziz, F. Creed, E. A. Houghton, L. Hungin et al., Guidelines on the irritable bowel syndrome: mechanisms and practical management, Gut, vol.56, issue.12, p.1770, 2007.
DOI : 10.1136/gut.2007.119446

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2095723/pdf

R. Lovell and A. Ford, Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis, Clinical Gastroenterology and Hepatology, vol.10, issue.7, pp.712-721, 2012.
DOI : 10.1016/j.cgh.2012.02.029

G. Enders, J. Enders, and I. Liber, Le charme discret de l'intestin : Tout sur un organe mal aimé, Actes Sud Editions, 2015.

H. Duboc, M. Dior, and B. Coffin, Le syndrome de l???intestin irritable??: nouvelles pistes physiopathologiques et cons??quences pratiques, La Revue de M??decine Interne, vol.37, issue.8, pp.536-579, 2016.
DOI : 10.1016/j.revmed.2015.12.030

S. Lee, D. Yoon, S. Lee, J. Kim, K. Choi et al., The association between irritable bowel syndrome and the coexistence of depression and insomnia, Journal of Psychosomatic Research, vol.93, pp.1-5, 2017.
DOI : 10.1016/j.jpsychores.2016.12.007

D. Gros, M. Antony, R. Mccabe, and R. Swinson, Frequency and severity of the symptoms of irritable bowel syndrome across the anxiety disorders and depression, Journal of Anxiety Disorders, vol.23, issue.2, pp.290-296, 2009.
DOI : 10.1016/j.janxdis.2008.08.004

P. Sabaté, Intestin irritable, les raisons de la colère

C. Brun-strang, M. Dapoigny, A. Lafuma, J. Wainsten, and F. Fagnani, Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study, European Journal of Gastroenterology & Hepatology, vol.19, issue.12, pp.1097-103, 2007.
DOI : 10.1097/MEG.0b013e3282f1621b

C. Canavan, J. West, and T. Card, Review article: the economic impact of the irritable bowel syndrome, Alimentary Pharmacology & Therapeutics, vol.26, issue.Suppl. S1, pp.1023-1057, 2014.
DOI : 10.1111/j.1365-2036.2007.03370.x

C. Canavan, J. West, and T. Card, Calculating Total Health Service Utilisation and Costs from Routinely Collected Electronic Health Records Using the Example of Patients with Irritable Bowel Syndrome Before and After Their First Gastroenterology Appointment, PharmacoEconomics, vol.4, issue.3, pp.181-94, 2016.
DOI : 10.1016/j.jval.2012.04.014

A. Michielan, D. Incà, and R. , Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut, Mediators of Inflammation, vol.272, issue.4, 2015.
DOI : 10.1017/s0029665114001621

M. Fujiwara, M. Shibata, Y. Nomiyama, T. Sugimoto, F. Hirata et al., Formation of 5-hydroxykynurenine and 5-hydroxykynurenamine from 5-hydroxytryptophan in rabbit small intestine, Proceedings of the National Academy of Sciences, vol.76, issue.3, pp.1145-1154, 1979.
DOI : 10.1073/pnas.76.3.1145

G. Clarke, P. Fitzgerald, J. Cryan, E. Cassidy, E. Quigley et al., Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort, BMC Gastroenterology, vol.98, issue.1???2, p.6, 2009.
DOI : 10.1016/j.jad.2006.07.013

T. Piche, Anomalies pari??tales et de la flore au cours du syndrome de l???intestin irritable, Gastroent??rologie Clinique et Biologique, vol.33, issue.1, pp.40-47, 2009.
DOI : 10.1016/S0399-8320(09)71524-6

T. Piche, Tight junctions and IBS - the link between epithelial permeability, low-grade inflammation, and symptom generation?, Neurogastroenterology & Motility, vol.53, issue.3, pp.296-302, 2014.
DOI : 10.1136/gut.2003.015867

R. Levy, K. Olden, B. Naliboff, L. Bradley, C. Francisconi et al., Psychosocial Aspects of the Functional Gastrointestinal Disorders, Gastroenterology, vol.130, issue.5, pp.1447-58, 2006.
DOI : 10.1053/j.gastro.2005.11.057

S. Pellissier and B. Bonaz, The Place of Stress and Emotions in the Irritable Bowel Syndrome, Vitam Horm. 1 janv, vol.103, pp.327-54, 2017.
DOI : 10.1016/bs.vh.2016.09.005

M. Alberganti, Notre alimentation a-t-elle perdu ses qualités nutritives? [Internet]. France Culture, 2016.

C. Kousmine and C. La-méthode-kousmine, Alimentation saine, apport de vitamines et minéraux, hygiène intestinale, implications psychologiques. Bernex-Genève; Saint-Julienen-Genevois: Jouvence editions, 2011.

N. Campbell-mcbride, L. Montagnier, P. Besson, G. Mouton, and N. Barrié, Le syndrome entéropsychologique, GAPS. Cottens, 2011.

D. Shepherd and D. Gibson, The Complete Low-FODMAP Diet: The revolutionary plan for managing symptoms in IBS, Crohn's disease, coeliac disease and other digestive disorders. Vermilion, 2014.

M. Simrén, E. Björnsson, and H. Abrahamsson, High interdigestive and postprandial motilin levels in patients with the irritable bowel syndrome, Neurogastroenterology and Motility, vol.322, issue.1, pp.51-58, 2005.
DOI : 10.1046/j.1365-2036.2000.00868.x

A. Ropert and G. Bouguen, Troubles de la motricit?? intestinale et hypersensibilit?? visc??rale dans le syndrome de l???intestin irritable, Gastroent??rologie Clinique et Biologique, vol.33, pp.35-44, 2009.
DOI : 10.1016/S0399-8320(09)71523-4

H. Mertz, B. Naliboff, J. Munakata, N. Niazi, and E. Mayer, Altered rectal perception is a biological marker of patients with irritable bowel syndrome, Gastroenterology, vol.109, issue.1, pp.40-52, 1995.
DOI : 10.1016/0016-5085(95)90267-8

R. Wijngaard, . Van-den, T. Klooker, W. Jonge, . De et al., Peripheral relays in stress-induced activation of visceral afferents in the gut, Autonomic Neuroscience, vol.153, issue.1-2, pp.99-105, 2010.
DOI : 10.1016/j.autneu.2009.07.004

M. El-salhy, Is irritable bowel syndrome an organic disorder?, World Journal of Gastroenterology, vol.20, issue.2, p.384, 2014.
DOI : 10.3748/wjg.v20.i2.384

M. Arumugam, J. Raes, E. Pelletier, L. Paslier, D. Yamada et al., Enterotypes of the human gut microbiome, Nature, vol.12473, issue.7346, pp.174-80, 2011.
URL : https://hal.archives-ouvertes.fr/cea-00903625

I. Bjarnason, A. Macpherson, and D. Hollander, Intestinal permeability: An overview, Gastroenterology, vol.108, issue.5, pp.1566-81, 1995.
DOI : 10.1016/0016-5085(95)90708-4

L. Berthelot and J. Warnet, Les Secrets de l'intestin Filtre de notre corps. S.l.: Le Livre de Poche, 2015.

A. Berstad, J. Raa, and J. Valeur, Tryptophan: ???essential??? for the pathogenesis of irritable bowel syndrome?, Scandinavian Journal of Gastroenterology, vol.13, issue.1, pp.1493-1501, 2014.
DOI : 10.1038/ni.2213

A. Slyepchenko, M. Maes, F. Jacka, C. Köhler, T. Barichello et al., Gut Microbiota, Bacterial Translocation, and Interactions with Diet: Pathophysiological Links between Major Depressive Disorder and Non-Communicable Medical Comorbidities, Psychotherapy and Psychosomatics, vol.86, issue.1, pp.31-46, 2017.
DOI : 10.1159/000448957

N. Koloski, M. Jones, J. Kalantar, M. Weltman, J. Zaguirre et al., The brain???gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study, Gut, vol.61, issue.9, pp.1284-90, 2012.
DOI : 10.1136/gutjnl-2011-300474

B. Bonaz and C. Bernstein, Brain-Gut Interactions in Inflammatory Bowel Disease, Gastroenterology, vol.144, issue.1, pp.36-49, 2013.
DOI : 10.1053/j.gastro.2012.10.003

URL : https://hal.archives-ouvertes.fr/inserm-00745108

G. Fond, C. G. Eberl, G. Leboyer, and M. , The potential role of microbiota in major psychiatric disorders: Mechanisms, preclinical data, gastro-intestinal comorbidities and therapeutic options. Presse Medicale Paris Fr, janv, vol.45, issue.1, pp.7-19, 1983.

B. Pierrehumbert and . Le-premier-lien, Théorie de l'attachement. Paris: Editions Odile Jacob, 2003.

J. Young, J. Klosko, M. Weishaar, J. Cottraux, and B. Pascal, La thérapie des schémas : Approche cognitive des troubles de la personnalité, 2005.

G. Fond, W. Boukouaci, C. G. Regnault, A. Eberl, G. Hamdani et al., The ???psychomicrobiotic???: Targeting microbiota in major psychiatric disorders: A systematic review, Pathologie Biologie, vol.63, issue.1, pp.35-42, 2015.
DOI : 10.1016/j.patbio.2014.10.003

O. Coudron and B. Pourrias, Guide des ordonnances de nutrition. Paris: Santé; 2014

E. Mayer and C. Roptin, La connexion cerveau-intestin : Agir avec efficacité sur cette relation essentielle qui gouverne notre humeur, notre comportement et notre santé dans sa globalité : c'est possible ! Guy Trédaniel éditeur, 2017.

G. Raphaël, Le serpent de mer de l'immuno-psychiatrie : les liens entre inflammation et dépression -Encéphale 2017 -Les vidéos du congrès de l'Encéphale, 2017.

K. Neufeld, N. Kang, J. Bienenstock, and J. Foster, Reduced anxiety-like behavior and central neurochemical change in germ-free mice, Neurogastroenterology & Motility, vol.22, issue.Suppl 1, pp.255-64, 2011.
DOI : 10.1152/ajpgi.90511.2008

URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2010.01620.x/pdf

E. Sender, Le microbiote allié de notre cerveau [Internet]. Sciences et Avenir, 2016.

V. Sharma, A. Sharma, A. Sharma, R. Guleria, and R. Deshmukh, Depression: An Immuno- Inflammatory Cascade. Ar?iv Kaynak Tarama Derg, p.223, 2016.
DOI : 10.17827/aktd.204348

URL : https://doi.org/10.17827/aktd.204348

T. Dinan and J. Cryan, Regulation of the stress response by the gut microbiota: Implications for psychoneuroendocrinology, Psychoneuroendocrinology, vol.37, issue.9, pp.1369-78, 2012.
DOI : 10.1016/j.psyneuen.2012.03.007

P. Kennedy, J. Cryan, E. Quigley, T. Dinan, and G. Clarke, A sustained hypothalamicpituitary-adrenal axis response to acute psychosocial stress in irritable bowel syndrome

S. Park, B. Naliboff, W. Shih, A. Presson, E. Videlock et al., Resilience is decreased in irritable bowel syndrome and associated with symptoms and cortisol response, Neurogastroenterology & Motility, vol.62
DOI : 10.1146/annurev-med-012309-103958

A. Mulak and B. Bonaz, Irritable bowel syndrome: a model of the brain-gut interactions, Med Sci Monit Int Med J Exp Clin Res. avr, vol.10, issue.4, pp.55-62, 2004.

A. T. Beck, R. A. Steer, and G. M. Garbin, Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation, Clinical Psychology Review, vol.8, issue.1, pp.77-100, 1988.
DOI : 10.1016/0272-7358(88)90050-5

L. Collet and J. Cottraux, The shortened Beck depression inventory (13 items) Study of the concurrent validity with the Hamilton scale and Widlöcher's retardation scale], L'Encephale. avr, vol.12, issue.2, pp.77-86, 1986.

A. Zigmond and R. Snaith, The Hospital Anxiety and Depression Scale, Acta Psychiatrica Scandinavica, vol.141, issue.6, pp.361-70, 1983.
DOI : 10.1001/archpsyc.1974.01760160005001

I. Bjelland, A. Dahl, T. Haug, and D. Neckelmann, The validity of the Hospital Anxiety and Depression Scale, Journal of Psychosomatic Research, vol.52, issue.2, pp.69-77, 2002.
DOI : 10.1016/S0022-3999(01)00296-3

R. Snaith, The Hospital Anxiety And Depression Scale, Health and Quality of Life Outcomes, vol.1, issue.1, p.29, 2003.
DOI : 10.1186/1477-7525-1-29

A. Higashi, H. Yashiro, K. Kiyota, H. Inokuchi, H. Hatta et al., Validation of the hospital anxiety and depression scale in a gastro-intestinal clinic, Nihon Shokakibyo Gakkai Zasshi Jpn J Gastro-Enterol. déc, vol.93, issue.12, pp.884-92, 1996.

D. Riché, Hyperperméabilité intestinale chez le sportif : mécanismes, conséquences et prise en charge nutritionelle, NAFAS, pp.17-29, 2004.

F. Jacka, O. Neil, A. Opie, R. Itsiopoulos, C. Cotton et al., A randomised controlled trial of dietary improvement for adults with major depression (the ???SMILES??? trial), BMC Medicine, vol.49, issue.12, p.23, 2017.
DOI : 10.1177/0004867415617657

R. Harris, S. Hayes, C. Penet, and L. Milleville, Passez à l'ACT : Pratique de la thérapie d'acceptation et d'engagement, 2012.
DOI : 10.3917/dbu.harri.2012.01

D. Shepherd and D. Gibson, Programme Fodmaps : vos intestins vous diront merci ! Vanves: Marabout; 2016

P. Gibson, The evidence base for efficacy of the low FODMAP diet in irritable bowel syndrome: is it ready for prime time as a first-line therapy?, Journal of Gastroenterology and Hepatology, vol.41, issue.1, pp.32-37, 2017.
DOI : 10.1111/apt.13202

J. Barrett, How to institute the low-FODMAP diet, Journal of Gastroenterology and Hepatology, vol.144, issue.2, pp.8-10, 2017.
DOI : 10.1016/j.ijfoodmicro.2010.10.007

URL : http://onlinelibrary.wiley.com/doi/10.1111/jgh.13686/pdf

H. Staudacher, Nutritional, microbiological and psychosocial implications of the low FODMAP diet, Journal of Gastroenterology and Hepatology, vol.20, issue.43, pp.16-25, 2017.
DOI : 10.3748/wjg.v20.i43.16215

M. Camilleri and G. Boeckxstaens, Dietary and pharmacological treatment of abdominal pain in IBS, Gut, vol.152, issue.5, pp.966-74, 2017.
DOI : 10.1136/gutjnl-2016-313425

P. Bron, M. Kleerebezem, R. Brummer, P. Cani, A. Mercenier et al., Abstract, British Journal of Nutrition, vol.4, issue.01, pp.93-107, 2017.
DOI : 10.1038/ncomms6648

M. Nébot-vivinus, C. Harkat, H. Bzioueche, C. Cartier, R. Plichon-dainese et al., Multispecies probiotic protects gut barrier function in experimental models, World Journal of Gastroenterology, vol.20, issue.22, pp.6832-6875, 2014.
DOI : 10.3748/wjg.v20.i22.6832

A. Slyepchenko, A. Carvalho, D. Cha, S. Kasper, and R. Mcintyre, Gut Emotions - Mechanisms of Action of Probiotics as Novel Therapeutic Targets for Depression and Anxiety Disorders, CNS & Neurological Disorders - Drug Targets, vol.13, issue.10, pp.1770-86, 2014.
DOI : 10.2174/1871527313666141130205242

A. Logan and M. Katzman, Major depressive disorder: probiotics may be an adjuvant therapy, Medical Hypotheses, vol.64, issue.3, pp.533-541, 2005.
DOI : 10.1016/j.mehy.2004.08.019

L. Steenbergen, R. Sellaro, S. Van-hemert, J. Bosch, and L. Colzato, A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood, Brain, Behavior, and Immunity, vol.48, pp.258-64, 2015.
DOI : 10.1016/j.bbi.2015.04.003

T. Dinan, C. Stanton, and J. Cryan, Psychobiotics: A Novel Class of Psychotropic, Biological Psychiatry, vol.74, issue.10, pp.720-726, 2013.
DOI : 10.1016/j.biopsych.2013.05.001

A. Sarkar, S. Lehto, S. Harty, T. Dinan, J. Cryan et al., Psychobiotics and the Manipulation of Bacteria???Gut???Brain Signals, Trends in Neurosciences, vol.39, issue.11, pp.763-81, 2016.
DOI : 10.1016/j.tins.2016.09.002

. La-documentation-française, Effets des probiotiques et prébiotiques sur la flore et l'immunité de l'homme adulte : Effects of probiotics and prebiotics on flora and immunity in adults, 2005.

N. Delzenne, La modulation du microbiote par les prébiotiques est-elle possible ? Prat En Nutr Santé Aliment, p.17, 2015.
DOI : 10.1016/j.pranut.2015.06.004

R. Rao and G. Samak, Role of Glutamine in Protection of Intestinal Epithelial Tight Junctions, J Epithel Biol Pharmacol. janv, vol.5, pp.47-54, 2012.

M. Kim and H. Kim, The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases, International Journal of Molecular Sciences, vol.88, issue.5, 2017.
DOI : 10.1016/S0899-9007(02)00817-1

A. Kalueff and D. Nutt, Role of GABA in anxiety and depression, Depression and Anxiety, vol.30, issue.7, pp.495-517, 2007.
DOI : 10.1007/s00221-002-1369-1

G. Sturniolo, W. Fries, E. Mazzon, D. Leo, V. Barollo et al., Effect of zinc supplementation on intestinal permeability in experimental colitis, Journal of Laboratory and Clinical Medicine, vol.139, issue.5, pp.311-316, 2002.
DOI : 10.1067/mlc.2002.123624

M. Osanai, N. Nishikiori, M. Murata, H. Chiba, T. Kojima et al., Cellular Retinoic Acid Bioavailability Determines Epithelial Integrity: Role of Retinoic Acid Receptor ?? Agonists in Colitis, Molecular Pharmacology, vol.71, issue.1, pp.250-258, 2007.
DOI : 10.1124/mol.106.029579

. Afssaps, Médicaments antidépresseurs dans le traitement des troubles dépressifs et des troubles anxieux de l'adulte. Afssaps, 2006.

A. Cipriani, T. Furukawa, G. Salanti, J. Geddes, J. Higgins et al., Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis, The Lancet, vol.373, issue.9665, pp.746-58, 2009.
DOI : 10.1016/S0140-6736(09)60046-5

J. Gale and L. Houghton, Alpha 2 Delta (??2??) Ligands, Gabapentin and Pregabalin: What is the Evidence for Potential Use of These Ligands in Irritable Bowel Syndrome, Frontiers in Pharmacology, vol.2, p.28, 2011.
DOI : 10.3389/fphar.2011.00028

D. Baldwin, J. Den-boer, G. Lyndon, B. Emir, E. Schweizer et al., Efficacy and safety of pregabalin in generalised anxiety disorder: A critical review of the literature, Journal of Psychopharmacology, vol.68, issue.11, pp.1047-60, 2015.
DOI : 10.1007/s00228-012-1213-x

M. Vitali, E. Tedeschini, M. Mistretta, K. Fehling, F. Aceti et al., Adjunctive Pregabalin in Partial Responders With Major Depressive Disorder and Residual Anxiety, Journal of Clinical Psychopharmacology, vol.33, issue.1, pp.95-103, 2013.
DOI : 10.1097/JCP.0b013e31827b9351

P. Cuijpers, M. Berking, G. Andersson, L. Quigley, A. Kleiboer et al., A Meta-Analysis of Cognitive-Behavioural Therapy for Adult Depression, Alone and in Comparison with other Treatments, The Canadian Journal of Psychiatry, vol.57, issue.4, pp.376-85, 2013.
DOI : 10.1146/annurev.psych.57.102904.190044

S. Windgassen, R. Moss-morris, J. Chilcot, A. Sibelli, K. Goldsmith et al., The journey between brain and gut: A systematic review of psychological mechanisms of treatment effect in irritable bowel syndrome, British Journal of Health Psychology, vol.67, issue.2, 2017.
DOI : 10.1111/j.1600-0447.1983.tb09716.x

K. Cooper, J. Gregory, I. Walker, S. Lambe, and P. Salkovskis, Cognitive Behaviour Therapy for Health Anxiety: A Systematic Review and Meta-Analysis, Behavioural and Cognitive Psychotherapy, vol.343, issue.02, pp.110-133, 2017.
DOI : 10.1016/0005-7967(86)90041-0

URL : https://www.cambridge.org/core/services/aop-cambridge-core/content/view/1D47C1A6EFE00BEB70A9CEF97D7F58BA/S1352465816000527a.pdf/div-class-title-cognitive-behaviour-therapy-for-health-anxiety-a-systematic-review-and-meta-analysis-div.pdf

K. Laird, E. Tanner-smith, A. Russell, S. Hollon, and L. Walker, Comparative efficacy of psychological therapies for improving mental health and daily functioning in irritable bowel syndrome: A systematic review and meta-analysis, Clinical Psychology Review, vol.51, pp.142-52, 2017.
DOI : 10.1016/j.cpr.2016.11.001

S. Kinsinger, Cognitive-behavioral therapy for patients with irritable bowel syndrome: current insights, Psychology Research and Behavior Management, vol.10, pp.231-238, 2017.
DOI : 10.2147/PRBM.S120817

S. Hayes, Acceptance and Commitment Therapy, Relational Frame Theory, and the Third Wave of Behavioral and Cognitive Therapies ??? Republished Article, Behavior Therapy, vol.47, issue.6, pp.869-85, 2016.
DOI : 10.1016/j.beth.2016.11.006

K. Rohde, D. Adolph, D. Dietrich, and J. Michalak, Mindful attention regulation and non-judgmental orientation in depression: A multi-method approach, Biological Psychology, vol.101, pp.36-43, 2014.
DOI : 10.1016/j.biopsycho.2014.06.009

J. Serpa, S. Taylor, and K. Tillisch, Mindfulness-based Stress Reduction (MBSR) Reduces Anxiety, Depression, and Suicidal Ideation in Veterans, Medical Care, vol.52, issue.12, pp.19-24, 2014.
DOI : 10.1097/MLR.0000000000000202

K. Rod, Observing the Effects of Mindfulness-Based Meditation on Anxiety and Depression in Chronic Pain Patients, Psychiatr Danub. sept, vol.27, issue.1, pp.209-211, 2015.

J. Williams and W. Kuyken, Mindfulness-based cognitive therapy: a promising new approach to preventing depressive relapse, The British Journal of Psychiatry, vol.200, issue.5, pp.359-60, 2012.
DOI : 10.1192/bjp.bp.111.104745

S. Zomorodi, S. Abdi, and S. Tabatabaee, Comparison of long-term effects of cognitivebehavioral therapy versus mindfulness-based therapy on reduction of symptoms among patients suffering from irritable bowel syndrome, Gastroenterol Hepatol Bed Bench, vol.7, issue.2, pp.118-142, 2014.

S. Sánchez, B. , G. Roales-nieto, J. Ferreira, N. et al., New psychological therapies for irritable bowel syndrome: mindfulness, acceptance and commitment therapy (ACT) Rev Espanola Enfermedades Dig Organo Of Soc Espanola Patol Dig, 2017.

S. Zomorrodi, R. Tabatabaie, S. Azadfallah, P. Ebrahimidaryani, N. Arbabi et al., Long Term Effects of Mindfulness on Quality of life in Irritable Bowel Syndrome, Iran J Psychiatry. avr, vol.10, issue.2, pp.100-105, 2015.

P. Lindfors, B. Ljótsson, E. Bjornsson, H. Abrahamsson, and M. Simrén, Patient satisfaction after gut-directed hypnotherapy in irritable bowel syndrome, Neurogastroenterology & Motility, vol.46, issue.Suppl 4, pp.169-86, 2013.
DOI : 10.1097/MCG.0b013e318225f545

A. Alladin, Evidence-Based Hypnotherapy for Depression, International Journal of Clinical and Experimental Hypnosis, vol.149, issue.2, pp.165-85, 2010.
DOI : 10.1037/0021-843X.89.3.333

URL : http://www.tandfonline.com/doi/pdf/10.1080/00207140903523194?needAccess=true

A. Alladin, Cognitive Hypnotherapy for Major Depressive Disorder, American Journal of Clinical Hypnosis, vol.8, issue.4, pp.275-93, 2012.
DOI : 10.1080/00207140903523228

S. Peters, C. Yao, H. Philpott, G. Yelland, J. Muir et al., Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome, Alimentary Pharmacology & Therapeutics, vol.11, issue.5, pp.447-59, 2016.
DOI : 10.2147/NDT.S61665

T. Algladi, M. Harris, P. Whorwell, P. Paine, and S. Hamdy, Modulation of human visceral sensitivity by noninvasive magnetoelectrical neural stimulation in health and irritable bowel syndrome, PAIN, vol.156, issue.7, pp.1348-56, 2015.
DOI : 10.1097/j.pain.0000000000000187

A. Brunoni, A. Chaimani, A. Moffa, L. Razza, W. Gattaz et al., Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes, JAMA Psychiatry, vol.74, issue.2, pp.143-52, 2017.
DOI : 10.1001/jamapsychiatry.2016.3644

O. Grundmann and S. Yoon, Complementary and alternative medicines in irritable bowel syndrome: An integrative view, World Journal of Gastroenterology, vol.20, issue.2, pp.346-62, 2014.
DOI : 10.3748/wjg.v20.i2.346

URL : http://doi.org/10.3748/wjg.v20.i2.346

L. Balestriere, Freud et la question des origines De Boeck Supérieur, 2008.
DOI : 10.3917/dbu.bales.2008.01